Bomedemstat

DB17234InvestigationalSmall molecule

Bomedemstat: Overview.

Mechanism: Pharmacologically active on Lysine-specific histone demethylase 1A
Curator reviewed
Formula / weight: C₂₈H₃₄FN₇O₂ · 519.625 g/mol (avg)
Also known as: Benzamide, n-((1s)-4-(((1r,2s)-2-(4-fluorophenyl)cyclopropyl)amino)-1-((4-methyl-1-piperazinyl)carbonyl)butyl)-4-(1h-1,2,3-triazol-1-yl)- · N-((1s)-4-(((1r,2s)-2-(4-fluorophenyl)cyclopropyl)amino)-1-((4-methyl-1-piperazinyl)carbonyl)butyl)-4-(1h-1,2,3-triazol-1-yl)benzamide
Code names: IMG-7289

Resolves to

Compound

Structure

InChIKeyKQKBMHGOHXOHTD-KKUQBAQOSA-NSMILESCN1CCN(CC1)C(=O)[C@H](CCCN[C@@H]1C[C@H]1C1=CC=C(F)C=C1)NC(=O)C1=CC=C(C=C1)N1C=CN=N1

Targets

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

16Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bomedemstat, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.